Download
EU secures over 50,000 additional doses of Bavarian Nordic's monkeypox vaccine
CGTN

The European Commission has secured about 54,000 additional doses of the monkeypox vaccine developed by the biotech firm Bavarian Nordic as concern mounts over the disease amid a spike in cases, it said in a statement. The supply deal follows a first contract signed in June when the EU ordered about 110,000 Bavarian Nordic vaccine doses.

Search Trends